openPR Logo
Press release

Influenza Vaccine Market Projected to Reach $6.20 billion by 2026 - AstraZeneca, Biodiem, CSL, Emergent , F. Hoffmann-La Roche, Gamma Vaccines, GlaxoSmithKline, Merck, Novartis

11-28-2019 12:29 PM CET | Health & Medicine

Press release from: Premium Market Insights

Influenza Vaccine Market

Influenza Vaccine Market

Influenza vaccine market was valued at $3.96 billion in 2018 and is projected to reach $6.20 billion by 2026, registering a CAGR of 5.9% from 2019 to 2026.

Influenza, commonly known as flu, is a contagious respiratory infection caused by influenza viruses. Four types of influenza viruses include type A, B, C and D. The most common types of influenza viruses responsible for seasonal flu each year are type A and B. These viruses enter into the respiratory system of an individual and are transmitted to other individuals by direct contact or inhalation of virus-laden aerosols. The ideal method to prevent influenza is through vaccination.

Get Sample PDF For More Professional And Technical Insights at:
https://www.premiummarketinsights.com/sample/AMR00021331

The global influenza vaccines market is segmented into vaccine type, type, technology, age group, route of administration and region. By vaccine type, it is bifurcated into quadrivalent and trivalent. Depending on type, it is segregated into seasonal and pandemic. As per technology, it is classified into egg-based and cell-based. According to age group, it is divided into pediatric and adult. On the basis of route of administration, it is categorized into injection and nasal spray. Region wise, it is analyzed across North America, Europe, Asia-Pacific and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2026, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global influenza vaccine market is provided.
An extensive analysis of various regions provides insights that allows companies to strategically plan their business moves.

KEY MARKET SEGMENTS
- By Vaccine type
Quadrivalent
Trivalent
- By Type
Seasonal
Pandemic
- By Technology
Egg-based
Cell-based
- By Age Group
Pediatric
Adult
- By Route of Administration
Injection
Nasal Spray
- By Region
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Get Complete Report at: https://www.premiummarketinsights.com/buy/AMR00021331

Name: Sameer Joshi
Email: sales@premiummarketinsights.com
Organization: Premium Market Insights
Phone: +1-646-491-9876

Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Influenza Vaccine Market Projected to Reach $6.20 billion by 2026 - AstraZeneca, Biodiem, CSL, Emergent , F. Hoffmann-La Roche, Gamma Vaccines, GlaxoSmithKline, Merck, Novartis here

News-ID: 1873666 • Views:

More Releases from Premium Market Insights

Third Party Logistics Market report explores the huge growth in future scope 2022-2030
Third Party Logistics Market report explores the huge growth in future scope 202 …
The Third party logistics market was valued at US$ 1273.11 million in 2022 and is projected to reach US$ 1929.18 million by 2030; it is expected to register a CAGR of 5.33% during 2022-2030. Get Sample Pdf: https://www.premiummarketinsights.com/sample/TIP00003743?utm_source=OpenPr&utm_medium=10640 The e-commerce ensures timely delivery and if the goods or products are returned then the company has to manage all the operations in reverse logistics. In the e-commerce business, 3PL provider deliver flexibility &
HVAC System Market 2022 Best Workable Strategy That Will Help to Boost your Revenue Till 2028
HVAC System Market 2022 Best Workable Strategy That Will Help to Boost your Reve …
The HVAC system market analysis is projected to reach 579.75 million by 2030 from US$ 246.10 billion in 2022 at a CAGR of 11.3% from 2022 to 2028. Get Sample Pdf: https://www.premiummarketinsights.com/sample/TIP00073598?utm_source=OpenPr&utm_medium=10640 The usage of air conditioners is our safeguard once the common temperature increases. However, many people are seen to be aware of how necessary it is to decide on an air conditioner unit and the way how it is important
HVAC chillers Market Dynamic Growth Factors, COVID-19 impact on Industry Share and Outlook 2021-2028
HVAC chillers Market Dynamic Growth Factors, COVID-19 impact on Industry Share a …
The HVAC chillers market is expected to grow from US$ 9,425.53 million in 2021 to US$ 12,878.92 million by 2028; it is estimated to grow at a CAGR of 4.56% during 2021-2028. Get Sample Pdf: https://www.premiummarketinsights.com/sample/TIP00035242?utm_source=OpenPr&utm_medium=10640 The improving economic conditions across the globe coupled with urbanization has led to the growth in the industrial sector. There has been a rise in the construction of medical centers, malls, complexes, hotels, commercial buildings and
Satellite Communication Terminal Market New Business Opportunities and Investment Research Report by 2023 to 2028.
Satellite Communication Terminal Market New Business Opportunities and Investmen …
The Satellite Communication Terminal Market size was valued at US$ 4,249.0 million in 2023 and it is expected to reach US$ 6,030.7 million by 2028; it is estimated to record a CAGR of 7.3% from 2023 to 2028. The satellite communication terminal market is growing because of the battlefield, the rise in public safety, and the desire for a reliable network during emergencies. The growth of the OTT platforms and IPTV

All 5 Releases


More Releases for Influenza

H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,
Influenza Vaccine Market | DPIResearch.com
According to the DPI Research new growth forecast report titled “Worldwide Influenza Vaccines Market Size | Forecast to 2027” to Witness Comprehensive Growth by 2027 DPI Research published a new report on Worldwide Influenza Vaccines Market. The research offers an extensive analysis of key players active in the Worldwide Influenza Vaccines Market. Detailed analysis on operating business segments, product portfolio, business performance, and key strategic developments is offered in the research.
Influenza Vaccines
Influenza Drugs and Vaccines Market describes its growth, size, share, Forecast and trends to 2025 Influenza Drugs and Vaccines Market Production and Demand Analysis 2019 to 2025 Influenza Drugs and Vaccines Market 2019 Manufacturing Analysis and Development Forecast 2025 Influenza Drugs and Vaccines Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Influenza Drugs and Vaccines Market to Insight By 2025: Top Key Vendors Influenza Drugs and Vaccines Market Insights 2019, Global and
The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In European Ma …
Europe Influenza Market Influenza is an upper respiratory tract disease and is caused by the influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children less than five years of age. The infection may be confirmed by testing
The Marketed Demand Of Influenza Vaccine Due To Influenza Disease In U.S. Market
Influenza is an upper respiratory tract disease and is caused by the Influenza virus. Influenza virus is mainly three types namely Influenza A, Influenza B, and Influenza C. Influenza is a communicable disease, spread through a flu cough, droplets from the infected people, sneeze or talks. Influenza commonly occurs in geriatric population and children with less than 5 years of age. The infection may be confirmed by testing the
Influenza Diagnostics Market
Influenza, commonly known as flu, is an infectious disease caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Influenza spreads through infectious respiratory secretions caused by aerosol formation due to direct contact with an infected person. This virus can cause seasonal epidemics with high levels of morbidity and mortality. According to WHO, these epidemics were estimated to result in about